• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Packaging Technology

    Elemental Impurities: The Time Has Come

    Continuous vs. Batch Production

    2018: The evolution of pharmaceutical packaging

    Formulation Development Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Sterling Pharma Invests £6M To Expand Offerings

    Bioclinica Announces Key Hires & Promotion

    PhoenixMD, STA Enter Manufacturing Agreement

    ProBioGen, Tizona Therapeutics Enter Collaboration

    Mayne Pharma Opens $80M Oral Solid Dose Facility
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Arcinova Receives £1.5M Innovate UK Grant

    Vetter Announces Visit from Illinois Governor

    Sterling Pharma Invests £6M To Expand Offerings

    PhoenixMD, STA Enter Manufacturing Agreement

    Mayne Pharma Opens $80M Oral Solid Dose Facility
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    INTERPHEX: Adents Showcases Cloud-Based Serialization Solution

    Almac Group Expands Packaging Capabilities

    Catalent Bolsters Clinical Supply Capabilities

    West, Stevanato Group Enter Ompi EZ-fill Alliance

    Pharmaceutical Packaging Technology
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Sterling Pharma Invests £6M To Expand Offerings

    PhoenixMD, STA Enter Manufacturing Agreement

    ProBioGen, Tizona Therapeutics Enter Collaboration

    INTERPHEX: Adents Showcases Cloud-Based Serialization Solution

    SAMDI Tech Enters Drug Discovery Collaboration
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Blockchain: The Next Big Trend in BioPharma?

    Emergent Completes Market Authorization

    Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle: ICH Q12

    LSNE Expands Capabilities and QC Laboratory Space

    Evotec Launches Drug Development Service
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    IQVIA

    Dow Development Laboratories, LLC

    Symbiosis Pharmaceutical Services

    Fusion Scientific Laboratories

    Legacy Pharmaceutical Packaging
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Teva, Handok Establish Business Venture

    Teva gains access to Korean market

    Related CONTENT
    • Teva-KOWA Pharma Co. To Acquire Taisho Pharma
    • Teva To Acquire Ratiopharm
    • Teva Gains Approval for Effexor Generic
    • 11 Teva Pharma
    • Financial Report: Teva 2Q11
    12.17.12
    Teva Pharmaceutical Industries, Ltd. and Handok Pharmaceuticals Co., Ltd. have established a business venture in South Korea giving Teva access to the Korean market. Teva will contribute its global resources, with responsibilities for manufacturing and supplying a range of medicines. Handok will be responsible for sales and marketing, distribution, and regulatory affairs. Teva will have a 51% stake in the new business venture and Handok will have 49%.
     
    "This is another significant step in our strategy to expand Teva’s presence in growing markets and excluding Japan, this is our first alliance in East Asia,” said Prof. Itzhak Krinsky, chairman of Teva Japan, chairman of Teva South Korea and head of business development Asia Pacific. “By utilizing Teva’s broad portfolio, R&D capabilities and its global infrastructure and know-how coupled with Handok’s expertise and strong reputation in Korea, Teva and Handok plan to assume a prominent position in the Korean pharmaceutical market. The business venture will enable patients to gain more access to the treatments they need including innovative therapies, such as our multiple sclerosis treatment Copaxone and branded generics.”
     
    "We are glad to open up new business opportunities through this business venture with Teva, which has a broad, unparalleled portfolio of innovative specialty therapeutics, generics, biosimilars and innovative medicines,” said Young-jin Kim, Handok’s chief executive officer. “We expect this business venture to contribute greatly to the Korean pharmaceutical industry by supplying medicines at more affordable prices and providing innovative treatment solutions for CNS, respiratory and women’s health.”
    Related Searches
    • Biosimilars
    • Development
    • Manufacturing
    • Regulatory Affairs
    Suggested For You
    Uhlmann Joins Open-SCS Group Uhlmann Joins Open-SCS Group
    Teva Appoints Chief Legal Officer Teva Appoints Chief Legal Officer
    Teva, Celltrion Enter Biosimilar Partnership Teva, Celltrion Enter Biosimilar Partnership
    Mayne Pharma Completes $652M Teva/Allergan Generic Acquisition   Mayne Pharma Completes $652M Teva/Allergan Generic Acquisition
    The Top 25 Report The Top 25 Report
    Teva, Takeda Establish New Business Venture Teva, Takeda Establish New Business Venture
    Teva, Takeda Establish Business Venture in Japan Teva, Takeda Establish Business Venture in Japan
    10	Teva Pharma 10 Teva Pharma
    Teva Japan Names CEO Teva Japan Names CEO
    12  Teva Pharma 12 Teva Pharma
    Financial Report: Teva 2Q11 Financial Report: Teva 2Q11
    11 Teva Pharma 11 Teva Pharma
    Teva Gains Approval for Effexor Generic Teva Gains Approval for Effexor Generic
    Teva To Acquire Ratiopharm  Teva To Acquire Ratiopharm
    Teva-KOWA Pharma Co. To Acquire Taisho Pharma Teva-KOWA Pharma Co. To Acquire Taisho Pharma

    Related Breaking News

    • Bio News | Breaking News | Industry News
      BioPlan Associates

      BioPlan Associates' 15th Annual Bio Mfg. Study is Open

      Participate and get a FREE aggregated summary of this year's results
      02.16.18

    • Bio News | Breaking News | Collaborations & Alliances
      Sandoz & Biocon Enter Global Partnership

      Sandoz & Biocon Enter Global Partnership

      To develop and commercialize biosimilars in immunology and oncology
      01.23.18

    • Trials & Filings
      Amgen, Allergan MVASI Biosimilar Wins EC Approval

      Amgen, Allergan MVASI Biosimilar Wins EC Approval

      Becomes first biosimilar bevacizumab approved by the EC for the treatment of certain types of cancers
      01.19.18


    • Aseptic Processing | Bio News | Breaking News | Facilities | Fill/Finish | Industry News
      New Aseptic Fill/Finish CMO Launches Operations

      New Aseptic Fill/Finish CMO Launches Operations

      Wuxi Griffin is a new contract manufacturer in China with Western management style and quality standards.
      01.16.18

    • Bio News | Breaking News | Collaborations & Alliances | Industry News | Trials & Filings
      Biocon and Mylan Receive ANVISA Approval

      Biocon and Mylan Receive ANVISA Approval

      For the first biosimilar Trastuzumab to be approved in Brazil
      01.02.18

    • Bio News | Industry News
      Teva Launches Generic Version of Reyataz

      Teva Launches Generic Version of Reyataz

      The drug is for the treatment of HIV-1
      12.29.17


    • Bio News | Breaking News | Industry News | Trials & Filings
      Clover Receives CTA Approval For Enbrel Biosimilar

      Clover Receives CTA Approval For Enbrel Biosimilar

      The CFDA's approval is for SCB-808, for the treatment of rheumatoid arthritis
      12.29.17

    • Bio News | Collaborations & Alliances | Industry News
      Selexis SA and Turgut Pharmaceuticals Expand Agreement

      Selexis SA and Turgut Pharmaceuticals Expand Agreement

      The expanded partnership adds onto the two existing commercial license agreements between the companies
      12.20.17

    • Bio News | Breaking News | Industry News
      FDA Approves Sanofi

      FDA Approves Sanofi's Admelog

      This is the first follow-on mealtime insulin ever approved by the FDA
      12.12.17


    • Trials & Filings
      Sandoz Phase I Biosimilar Achieves Positive Results

      Sandoz Phase I Biosimilar Achieves Positive Results

      Proposed biosimilar to Neulasta demonstrates PK, PD, safety and efficacy
      12.08.17

    • Bio News | Breaking News | Facilities | Industry News
      BIOCAD Launches New Mfg. Site in North Africa

      BIOCAD Launches New Mfg. Site in North Africa

      Russian company will make biosimilars of rituximab and bevacizumab for cancer
      12.01.17

    • Bio News | Breaking News | Facilities | Industry News
      Lonza Pharma & Biotech Launches Ibex Solutions

      Lonza Pharma & Biotech Launches Ibex Solutions

      Represents an innovative new concept in biological manufacturing and development
      07.31.17

    • Bio News | Breaking News | cGMP Manufacture | Facilities | Industry News
      Axis Biotec, PlantForm Enter Bio Mfg. Pact

      Axis Biotec, PlantForm Enter Bio Mfg. Pact

      Plans call for construction of an innovative tobacco-based biopharma expression and pilot manufacturing facility in Brazil
      06.26.17

    • Bio News | Breaking News | Facilities | Industry News
      Sartorius Stedim Biotech Launches Chemistry Testing Services

      Sartorius Stedim Biotech Launches Chemistry Testing Services

      To be offered by subsidiary BioOutsource
      05.05.17

    • Samsung Bioepis Obtains First Drug Approval in the U.S.

      Samsung Bioepis Obtains First Drug Approval in the U.S.

      FDA approves biosimilar Renflexis across all eligible indications
      04.24.17

    Breaking News
    • Sterling Pharma Invests £6M To Expand Offerings
    • AGC Chemicals to Feature Advanced Intermediates
    • Avema to Showcase Range of Services
    • Peter Stein to Deliver FDA Keynote Presentation
    • CPhI NA Conference to Focus on Fostering Innovation
    View Breaking News >
    CURRENT ISSUE

    April 2018

    • Pharmaceutical Packaging Technology
    • Elemental Impurities: The Time Has Come
    • Continuous vs. Batch Production
    • 2018: The evolution of pharmaceutical packaging
    • Formulation Development Trends
    • Changing Dynamics: The CDMO market in focus
    • Contract BioManufacturing in China: Creating a New Segment
    • View More >

    Copyright © 2018 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.